O’Ryan.Health, a leader in at-home pediatric healthcare innovation, today announced it has become the first US company to launch two, parent-led observational studies “The Healthy Kids Study” and “The JDM Study,” involving the in-home collection of pediatric blood from children. Juvenile Dermatomyositis (JDM) is an ultra-rare pediatric autoimmune disorder. These studies, made possible through a partnership with YourBio Health, a pioneer in capillary blood sampling, allow parents to safely and efficiently sample their children’s blood without having to travel to a medical facility.
Cardiovascular disease remains one of the leading causes of illness and death worldwide, placing significant pressure on healthcare systems and highlighting the importance of early diagnosis and timely intervention. As digital health technologies continue to evolve, wearable devices and artificial…
Behind every successful healthcare system is a supply chain that ensures medicines, medical devices and essential equipment reach the right place at the right time. While often operating behind the scenes, healthcare logistics has become one of the most important…